Shaygannejad, A.; Rafiei, N.; Vaheb, S.; Yazdan Panah, M.; Shaygannejad, V.; Mirmosayyeb, O.
The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis. Medicina 2024, 60, 1050.
https://doi.org/10.3390/medicina60071050
AMA Style
Shaygannejad A, Rafiei N, Vaheb S, Yazdan Panah M, Shaygannejad V, Mirmosayyeb O.
The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis. Medicina. 2024; 60(7):1050.
https://doi.org/10.3390/medicina60071050
Chicago/Turabian Style
Shaygannejad, Aysa, Nazanin Rafiei, Saeed Vaheb, Mohammad Yazdan Panah, Vahid Shaygannejad, and Omid Mirmosayyeb.
2024. "The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis" Medicina 60, no. 7: 1050.
https://doi.org/10.3390/medicina60071050
APA Style
Shaygannejad, A., Rafiei, N., Vaheb, S., Yazdan Panah, M., Shaygannejad, V., & Mirmosayyeb, O.
(2024). The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis. Medicina, 60(7), 1050.
https://doi.org/10.3390/medicina60071050